國立虎尾科技大學 |

Advances in Cancer Biomarkers = From biochemistry to clinic for a critical revision /

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	Advances in Cancer Biomarkers/ edited by Roberto Scatena.
其他題名:	From biochemistry to clinic for a critical revision /
其他作者:	Scatena, Roberto.
面頁冊數:	IX, 372 p. 27 illus., 21 illus. in color.online resource. :
Contained By:	Springer Nature eBook
標題:	Cancer research. -
電子資源:	https://doi.org/10.1007/978-94-017-7215-0
ISBN:	9789401772150

Advances in Cancer Biomarkers = From biochemistry to clinic for a critical revision /
Advances in Cancer BiomarkersFrom biochemistry to clinic for a critical revision /[electronic resource] :edited by Roberto Scatena. - 1st ed. 2015. - IX, 372 p. 27 illus., 21 illus. in color.online resource. - Advances in Experimental Medicine and Biology,8670065-2598 ;. - Advances in Experimental Medicine and Biology,889.

Prelims -- I Generality.- II Tumor markers-a critical revision -- Enzymes.- Hormones -- Oncofetal proteins.- Cytokeratins -- Carbohydrate markers -- Blood group antigens.- Genetic markers -- Various protein markers -- III Perspectives.- The role of Circulating tumor Cells as tumor markers -- Index.

At present there are a growing number of biomolecules under investigation to understand their potential role as cancer biomarker for diagnostic, prognostic and therapeutic purposes. Intriguingly, the state of art on cancer biomarkers research shows interesting and promising results together to clamorous failures. Also from a clinical point of view, there are contradictory results on routine clinical use of the present cancer biomarkers. Some patients may be simply monitored in their course by a periodic blood sample, but sometimes this monitoring shows dramatic limits. A lot of patients show serious and extensive relapses without significant change in serum concentrations of biomarkers tested. Often the physician who should utilize these biomarker does not entirely know their limits and the total potential applications as well and sometimes this knowledge is influenced by economical and marketing strategies. This limited and “polluted” knowledge may have dramatic consequences for patient. The aim of this book is to diffuse all aspects of cancer biomarkers, from their biochemical peculiarities to all clinical implications by passing through their physiology and pathophysiology. This critical approach towards old and new cancer biomarkers should foster a deepened and useful understanding of the diagnostic and prognostic index of these fundamental parameters of laboratory medicine and in the same time facilitating the research of new and more sensitive-specific signals of the cancer cell proliferation.

ISBN: 9789401772150

Standard No.: 10.1007/978-94-017-7215-0doiSubjects--Topical Terms:

1253664
Cancer research.

LC Class. No.: RC261-271

Dewey Class. No.: 614.5999

Advances in Cancer Biomarkers = From biochemistry to clinic for a critical revision /
LDR:03322nam a22004095i 4500 001 967489
003 DE-He213
005 20200705025335.0
007 cr nn 008mamaa
008 201211s2015 ne | s |||| 0|eng d
020 $a 9789401772150 $9 978-94-017-7215-0
024 7 $a 10.1007/978-94-017-7215-0 $2 doi
035 $a 978-94-017-7215-0
050 4 $a RC261-271
072 7 $a MJCL $2 bicssc
072 7 $a MED062000 $2 bisacsh
072 7 $a MJCL $2 thema
082 0 4 $a 614.5999 $2 23
245 1 0 $a Advances in Cancer Biomarkers $h [electronic resource] : $b From biochemistry to clinic for a critical revision / $c edited by Roberto Scatena.
250 $a 1st ed. 2015.
264 1 $a Dordrecht : $b Springer Netherlands : $b Imprint: Springer, $c 2015.
300 $a IX, 372 p. 27 illus., 21 illus. in color. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
490 1 $a Advances in Experimental Medicine and Biology, $x 0065-2598 ; $v 867
505 0 $a Prelims -- I Generality.- II Tumor markers-a critical revision -- Enzymes.- Hormones -- Oncofetal proteins.- Cytokeratins -- Carbohydrate markers -- Blood group antigens.- Genetic markers -- Various protein markers -- III Perspectives.- The role of Circulating tumor Cells as tumor markers -- Index.
520 $a At present there are a growing number of biomolecules under investigation to understand their potential role as cancer biomarker for diagnostic, prognostic and therapeutic purposes. Intriguingly, the state of art on cancer biomarkers research shows interesting and promising results together to clamorous failures. Also from a clinical point of view, there are contradictory results on routine clinical use of the present cancer biomarkers. Some patients may be simply monitored in their course by a periodic blood sample, but sometimes this monitoring shows dramatic limits. A lot of patients show serious and extensive relapses without significant change in serum concentrations of biomarkers tested. Often the physician who should utilize these biomarker does not entirely know their limits and the total potential applications as well and sometimes this knowledge is influenced by economical and marketing strategies. This limited and “polluted” knowledge may have dramatic consequences for patient. The aim of this book is to diffuse all aspects of cancer biomarkers, from their biochemical peculiarities to all clinical implications by passing through their physiology and pathophysiology. This critical approach towards old and new cancer biomarkers should foster a deepened and useful understanding of the diagnostic and prognostic index of these fundamental parameters of laboratory medicine and in the same time facilitating the research of new and more sensitive-specific signals of the cancer cell proliferation.
650 0 $a Cancer research. $3 1253664
650 0 $a Oncology . $3 1253469
650 0 $a Pharmacology. $3 583819
650 1 4 $a Cancer Research. $3 668358
650 2 4 $a Oncology. $3 593951
650 2 4 $a Pharmacology/Toxicology. $3 593882
700 1 $a Scatena, Roberto. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 888024
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9789401772143
776 0 8 $i Printed edition: $z 9789401772167
776 0 8 $i Printed edition: $z 9789402404203
830 0 $a Advances in Experimental Medicine and Biology, $x 0065-2598 ; $v 889 $3 1253792
856 4 0 $u https://doi.org/10.1007/978-94-017-7215-0
912 $a ZDB-2-SBL
912 $a ZDB-2-SXB
950 $a Biomedical and Life Sciences (SpringerNature-11642)
950 $a Biomedical and Life Sciences (R0) (SpringerNature-43708)